BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15905990)

  • 1. [Lymphadenectomy for testicular cancer. Diagnostic and prognostic significance as well as therapeutic benefit].
    Krege S; Rübben H
    Urologe A; 2005 Jun; 44(6):652-6. PubMed ID: 15905990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit].
    Borchers H; Jakse G
    Urologe A; 2005 Jun; 44(6):657-61. PubMed ID: 15891865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retroperitoneal lymph node dissection in testis cancer].
    Pottek T;
    Urologe A; 2004 Dec; 43(12):1514-20. PubMed ID: 15592708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of pelvic lymphadenectomy in clinically localised prostate cancer].
    Schumacher M; Burkhard FC; Studer UE
    Urologe A; 2005 Jun; 44(6):645-51. PubMed ID: 15871005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
    Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
    Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update.
    Gardner MW; Roytman TM; Chen C; Brandes SB; Kibel AS; Grubb RL; Bhayani SB; Figenshau RS
    J Endourol; 2011 Nov; 25(11):1753-7. PubMed ID: 21936630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.
    Carver BS; Cronin AM; Eggener S; Savage CJ; Motzer RJ; Bajorin D; Bosl GJ; Sheinfeld J
    Urology; 2010 Jun; 75(6):1431-5. PubMed ID: 20299079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph Node Yield in Primary Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumors.
    Nayan M; Jewett MA; Sweet J; Anson-Cartwright L; Bedard PL; Moore M; Chung P; Warde P; Hamilton RJ
    J Urol; 2015 Aug; 194(2):386-91. PubMed ID: 25823792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour.
    Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP
    BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Recurrence for Clinical Stage I and II Patients With Teratoma Only at Primary Retroperitoneal Lymph Node Dissection.
    Liu NW; Cary C; Strine AC; Beck SD; Masterson TA; Bihrle R; Foster RS
    Urology; 2015 Nov; 86(5):981-4. PubMed ID: 26232690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic retroperitoneal lymph node dissection for low-stage testicular cancer.
    Skolarus TA; Bhayani SB; Chiang HC; Brandes SB; Kibel AS; Landman J; Figenshau RS
    J Endourol; 2008 Jul; 22(7):1485-9. PubMed ID: 18613781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic RPLND for clinical stage I nonseminomatous germ cell testicular cancer: current status.
    Bhayani SB; Allaf ME; Kavoussi LR
    Urol Oncol; 2004; 22(2):145-8. PubMed ID: 15082014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatous testis cancer? A European perspective.
    Rassweiler JJ; Scheitlin W; Heidenreich A; Laguna MP; Janetschek G
    Eur Urol; 2008 Nov; 54(5):1004-15. PubMed ID: 18722704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of sentinel node biopsy for urological tumors].
    Wawroschek F; Harzmann R; Weckermann D
    Urologe A; 2005 Jun; 44(6):630-4. PubMed ID: 15891864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Klein EA
    BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroperitoneal lymph node dissection (RPLND).
    Zivanovic O; Sheinfeld J; Abu-Rustum NR
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S66-9. PubMed ID: 18789513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperative Retroperitoneal Surgery: Etiology and Clinical Outcome.
    Woldu SL; McKiernan JM
    Urol Clin North Am; 2015 Aug; 42(3):381-92. PubMed ID: 26216825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
    Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
    J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.